CERVARIX VACUNA RECOMBINANTE BIVALENTE ADSORBIDA CONTRA EL VIRUS DEL PAPILOMA HUMANO (TIPOS 16 Y 18) SUSPENSION INYECTABLE
Country: Venezuela
Language: Spanish
Source: Instituto Nacional de Higiene
Patient Information leaflet
(PIL)
30-08-2023
Public Assessment Report
(PAR)
15-02-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
VACUNA RECOMBINANTE BIVALENTE ADSORBIDA CONTRA EL VIRUS DEL PAPILOMA HUMANO
Available from:
GLAXOSMITHKLINE VENEZUELA C.A.
INN (International Name):
VACUNA RECOMBINANTE BIVALENTE ADSORBIDA CONTRA EL VIRUS DEL PAPILOMA HUMANO (TIPOS 16 Y 18)
Dosage:
20 mcg - 20 mcg / 0,5 mL
Pharmaceutical form:
SUSPENSION
Administration route:
INTRAMUSCULAR
Prescription type:
CON PRESCRIPCION FACULTATIVA
Manufactured by:
GLAXOSMITHKLINE BIOLOGICALS, S.A.
Authorization status:
VIGENTE
Authorization date:
2020-09-25
